SEC Tracker
Get the app

Alzamend Neuro ALZN

Alzamend Neuro sold $7.5 million in preferred shares

Alzamend Neuro (ALZN) filed an 8-K/A with the SEC on Nov 10, 2026, 4:30 pm ET. Source: the filing on SEC EDGAR.

Item 1.01 Enters material agreement, Item 3.02 Unregistered share sale, Item 5.03 Amends charter or bylaws

Form
8-K/A
Filed
Importance
Major
  1. Purchased 7,500 Preferred Shares for $7.5 million
  2. Amended agreement to reduce total financing to $10 million
  3. Purchaser is an affiliate of the company
  4. Registration statement for resale of common stock due by November 17, 2026

Written from the 8-K/A on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Alzamend Neuro files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.